Code of Federal Regulations Title 21, Volume 5, April 1, 2015
Versandkostenfrei!
Versandfertig in 1-2 Wochen
49,99 €
inkl. MwSt.
PAYBACK Punkte
25 °P sammeln!
Code of Federal Regulations Title 21, Volume 5, April 1, 2015 Containing parts Parts 300 to 499 Part 300; GENERAL Part 310; NEW DRUGS Part 312; INVESTIGATIONAL NEW DRUG APPLICATION Part 314; APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG Part 315; DIAGNOSTIC RADIOPHARMACEUTICALS Part 316; ORPHAN DRUGS Part 317; QUALIFYING PATHOGENS Part 320; BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS Part 328; OVER-THE-COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL Part 329; NONPRESCRIPTION HUMAN DRUG PRODUCTS SUBJECT TO SECTION 760 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT P...
Code of Federal Regulations Title 21, Volume 5, April 1, 2015 Containing parts Parts 300 to 499 Part 300; GENERAL Part 310; NEW DRUGS Part 312; INVESTIGATIONAL NEW DRUG APPLICATION Part 314; APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG Part 315; DIAGNOSTIC RADIOPHARMACEUTICALS Part 316; ORPHAN DRUGS Part 317; QUALIFYING PATHOGENS Part 320; BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS Part 328; OVER-THE-COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL Part 329; NONPRESCRIPTION HUMAN DRUG PRODUCTS SUBJECT TO SECTION 760 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT Part 330; OVER-THE-COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED Part 331; ANTACID PRODUCTS FOR OVER-THE-COUNTER (OTC) HUMAN USE Part 332; ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 333; TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 335; ANTIDIARRHEAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 336; ANTIEMETIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 338; NIGHTTIME SLEEP-AID DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 340; STIMULANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 341; COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 343; INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEUMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 344; TOPICAL OTIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 346; ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 347; SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 348; EXTERNAL ANALGESIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 349; OPHTHALMIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 350; ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 352; SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY] Part 355; ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 357; MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 358; MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE Part 361; PRESCRIPTION DRUGS FOR HUMAN USE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED: DRUGS USED IN RESEARCH Part 369; INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE-COUNTER SALE Parts 370-499; Reserved
Andere Kunden interessierten sich für
